Predictors of pain reduction among fibromyalgia patients using medical cannabis: a long-term prospective cohort study.

Our findings provide preliminary insights into the potential mechanisms of action underlying pain reductions among FM patients who are using medical cannabis. Given the high attrition rate (i.e., 75 %) observed in the present study at 12 months, our findings cannot be generalized to all FM patients who are using medical cannabis.